Coffee may reduce risk of breast cancer recurrence
the ONA take:
According to a new study, researchers at Lund University and Skane University Hospital in Sweden have found that coffee inhibits the growth of tumors and reduces the risk of recurrence in women with breast cancer treated with tamoxifen.
For the study, researchers analyzed data from 1,090 patients with breast cancer. They found that among the over 500 women who were treated with the estrogen receptor antagonist tamoxifen, those who drank at least two cups of coffee per day had half the risk of disease recurrence compared with those who drank less coffee or no coffee.
The study also showed that women who drank at least two cups per day had smaller breast tumors and fewer hormone-dependent tumors.
"If you like coffee and are also taking tamoxifen, there is no reason to stop drinking it. Just two cups a day is sufficient to make a difference," said study researchers.
Coffee inhibits the growth of tumors and reduces the risk of recurrence in women with breast cancer treated with tamoxifen.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|